Suchergebnisse - (Person:"Zhang, Wei")

PubPharm (471)

1

Allosteric SHP2 inhibition enhances regorafenib's effectiveness in colorectal cancer treatment

enthalten in: Biochemical and biophysical research communications | 2024

von Han, X. | Wang, W. | Wang, R. | +5

2

KDM5C-Mediated Recruitment of BRD4 to Chromatin Regulates Enhancer Activation and BET Inhibitor Sensitivity

enthalten in: Cancer research | 2024

von Qiang, Y. | Fan, J. | Xie, C. | +12

3

Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia : a randomized phase 3 trial with 5-year outcomes

enthalten in: Journal of cancer research and clinical oncology | 2024

von Tian, J. | Song, Y. | Zhang, G. | +24

4

Discovery of a nitroaromatic nannocystin with potent in vivo anticancer activity against colorectal cancer by targeting AKT1

enthalten in: Acta pharmacologica Sinica | 2024

von Zhang, H. | Xie, F. | Yuan, X. | +8

5

A new secondary metabolite from the marine-derived fungus Phomopsis lithocarpus FS508

enthalten in: Journal of Asian natural products research | 2024

von Tan, Z. | Chen, Y. | Zhang, J. | +3

6

Locoregional therapies for hepatocellular carcinoma : The current status and future perspectives

enthalten in: United European gastroenterology journal | 2024

von Chen, J. | Jin, Z. | Zhong, B. | +6

7

Molecular panorama of therapy resistance in prostate cancer : a pre-clinical and bioinformatics analysis for clinical translation

enthalten in: Cancer metastasis reviews | 2024

von Ashrafizadeh, M. | Zhang, W. | Tian, Y. | +3

8

Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor

enthalten in: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy | 2024

von Teng, Q. | Lei, Z. | Wang, J. | +9

9

Advances in DNA damage response inhibitors in colorectal cancer therapy

enthalten in: Acta biochimica et biophysica Sinica | 2024

von Yu, Y. | Jia, H. | Zhang, T. | +1

10

Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer : The Neotorch Randomized Clinical Trial

enthalten in: JAMA | 2024

von Lu, S. | Zhang, W. | Wu, L. | +63

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[48]